Sentinel Capital exits WellSpring Pharma

Sentinel Capital Partners has sold WellSpring Pharma Services. ANI Pharmaceuticals Inc, in a separate release, said it acquired WellSpring for $18 million cash. WellSpring, of Ontario, is a pharmaceutical contract manufacturing organization. UPDATE: Ancor Capital was also another seller.

DealsNorth AmericaUSBriefs